Medical treatment of heart failure with renin-angiotensin-aldosterone system inhibitors and beta-blockers in aortic stenosis: association with long-term outcome after aortic valve replacement.
Johan HopfgartenStefan K JamesLars LindhagenTomasz BaronElisabeth StåhleChristina ChristerssonPublished in: European heart journal open (2024)
The RAS inhibition was associated with a lower all-cause mortality after valve replacement in patients with both reduced and preserved LV-EF. Beta-blockade was associated with lower all-cause mortality only in patients with reduced LV-EF.
Keyphrases
- aortic stenosis
- aortic valve replacement
- aortic valve
- transcatheter aortic valve replacement
- angiotensin converting enzyme
- ejection fraction
- left ventricular
- transcatheter aortic valve implantation
- heart failure
- angiotensin ii
- coronary artery disease
- healthcare
- cardiac resynchronization therapy
- mitral valve
- atrial fibrillation